{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:22:33Z","timestamp":1792783353807,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi di Roma La Sapienza","id":[{"id":"https:\/\/ror.org\/02be6w209","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To compare the diagnostic performance of three different abbreviated MRI protocols simulated by extraction from a standard liver MRI protocol with hepatobiliary-specific contrast agent obtained for hepatocellular carcinoma (HCC) surveillance in patients candidates for liver transplantation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective study on cirrhotic patient population, undergoing MRI surveillance for HCC. All patients were candidates to liver transplantation with a total of 105\/195 patients previously treated with liver-directed therapy. From the complete liver MRI with hepatobiliary-specific contrast agent (cMRI), three simulated abbreviated MRI protocols were extracted: dynamic contrast-enhanced abbreviated MRI (Dyn-AMRI); hepatobiliary phase abbreviated MRI (HBP-AMRI) and non-enhanced abbreviated MRI (NE-AMRI). Three abdominal radiologists independently interpreted the simulated protocols.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>195 cirrhotic patients, candidates for liver transplantation, were analyzed. The overall sensitivity, specificity and accuracy of AMRI for HCC detection were 94%, 96% and 94% for Dyn-AMRI, 93%, 94% and 93% for HBP-AMRI, 90%, 90% and 90% for NE-AMRI. The interchangeability analysis revealed no significant difference between HBP-AMRI and cMRI and between cMRI and Dyn-AMRI. Regarding equivalence, agreement and interchangeability analysis, no significant differences were found in detection of HCC in patients previously undergoing liver-directed therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Both Dyn-AMRI and HBP-AMRI could be used in surveillance of cirrhotic patients, even after previous liver-direct therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11547-026-02259-0","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:55:15Z","timestamp":1783940115000},"page":"1452-1460","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic performance of abbreviated MRI in surveillance of patients with hepatocellular carcinoma candidates for liver transplantation"],"prefix":"10.1007","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9204-1608","authenticated-orcid":false,"given":"Monica","family":"Mattone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3553-8671","authenticated-orcid":false,"given":"Alessandro","family":"De Maio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8337-7652","authenticated-orcid":false,"given":"Alessandro","family":"Napoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4208-9691","authenticated-orcid":false,"given":"Carlo","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"issue":"5","key":"2259_CR1","first-page":"277","volume":"60","author":"A Jemal","year":"2010","unstructured":"Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60(5):277\u2013300","journal-title":"CA Cancer J Clin"},{"key":"2259_CR2","unstructured":"UNOS. Available from: http:\/\/www.unos.org"},{"issue":"3","key":"2259_CR3","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jhep.2012.12.005","volume":"58","author":"M Blachier","year":"2013","unstructured":"Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F (2013) The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol 58(3):593\u2013608","journal-title":"J Hepatol"},{"issue":"2","key":"2259_CR4","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep.29913","volume":"68","author":"JA Marrero","year":"2018","unstructured":"Marrero JA, Kulik LM, Sirlin CB et al (2018) Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American association for the study of liver diseases. Hepatology 68(2):723\u2013750","journal-title":"Hepatology"},{"key":"2259_CR5","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver 2018 EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma J Hepatol 69 1 182 236","DOI":"10.1016\/j.jhep.2018.03.019"},{"issue":"3","key":"2259_CR6","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1159\/000327577","volume":"29","author":"M Kudo","year":"2011","unstructured":"Kudo M, Izumi N, Kokudo N et al (2011) Management of hepatocellular carcinoma in Japan: consensus-based clinical practice guidelines proposed by the Japan society of hepatology 2010 updated version. Dig Dis 29(3):339\u2013364","journal-title":"Dig Dis"},{"issue":"2","key":"2259_CR7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s12072-010-9165-7","volume":"4","author":"M Omata","year":"2010","unstructured":"Omata M, Lesmana LA, Tateishi R et al (2010) Asian Pacific association for the study of the liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 4(2):439\u2013474","journal-title":"Hepatol Int"},{"issue":"4","key":"2259_CR8","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1001\/jamaoncol.2016.3147","volume":"3","author":"SY Kim","year":"2017","unstructured":"Kim SY, An J, Lim YS et al (2017) MRI with liver-specific contrast for surveillance of patients with cirrhosis at high risk of hepatocellular carcinoma. JAMA Oncol 3(4):456\u2013463","journal-title":"JAMA Oncol"},{"issue":"3","key":"2259_CR9","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/j.1572-0241.2006.00467.x","volume":"101","author":"A Colli","year":"2006","unstructured":"Colli A, Fraquelli M, Casazza G et al (2006) Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review. Am J Gastroenterol 101(3):513\u2013523","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"2259_CR10","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1053\/j.gastro.2018.01.064","volume":"154","author":"K Tzartzeva","year":"2018","unstructured":"Tzartzeva K, Obi J, Rich NE et al (2018) Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis. Gastroenterology 154(6):1706\u20131718","journal-title":"Gastroenterology"},{"issue":"1","key":"2259_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1365-2036.2009.04014.x","volume":"30","author":"A Singal","year":"2009","unstructured":"Singal A, Volk ML, Waljee A et al (2009) Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. Aliment Pharmacol Ther 30(1):37\u201347","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"2259_CR12","doi-asserted-by":"publisher","first-page":"5142","DOI":"10.1007\/s00261-021-03212-7","volume":"46","author":"G Hernandez-Meza","year":"2021","unstructured":"Hernandez-Meza G, Vietti Violi N, Said D et al (2021) MRI is the most commonly used imaging modality for HCC screening at a tertiary care transplant center. Abdom Radiol 46(11):5142\u20135151","journal-title":"Abdom Radiol"},{"issue":"1","key":"2259_CR13","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jhep.2021.01.041","volume":"75","author":"P Gupta","year":"2021","unstructured":"Gupta P, Soundararajan R, Patel A et al (2021) Abbreviated MRI for hepatocellular carcinoma screening: a systematic review and meta-analysis. J Hepatol 75(1):108\u2013119","journal-title":"J Hepatol"},{"key":"2259_CR14","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.3390\/diagnostics11091665","volume":"11","author":"DH Kim","year":"2021","unstructured":"Kim DH, Choi SH, Shim JH et al (2021) Magnetic resonance imaging for surveillance of hepatocellular carcinoma: a systematic review and meta-analysis. Diagnostics (Basel) 11:1665","journal-title":"Diagnostics (Basel)"},{"key":"2259_CR15","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJM199603143341104","volume":"334","author":"V Mazzaferro","year":"1996","unstructured":"Mazzaferro V, Regalia E, Doci R et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693\u2013699","journal-title":"N Engl J Med"},{"issue":"7","key":"2259_CR16","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1007\/s00261-017-1339-5","volume":"43","author":"JY Lee","year":"2018","unstructured":"Lee JY, Huo EJ, Weinstein S et al (2018) Evaluation of an abbreviated screening MRI protocol for patients at risk for hepatocellular carcinoma. Abdom Radiol 43(7):1627\u20131633","journal-title":"Abdom Radiol"},{"issue":"4","key":"2259_CR17","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3348\/kjr.2010.11.4.433","volume":"11","author":"Y Park","year":"2010","unstructured":"Park Y, Kim SH, Kim SH et al (2010) Gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI versus gadobenate dimeglumine (Gd-BOPTA)-enhanced MRI for preoperatively detecting hepatocellular carcinoma. Korean J Radiol 11(4):433\u2013440","journal-title":"Korean J Radiol"},{"issue":"1","key":"2259_CR18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s00261-017-1325-y","volume":"43","author":"AR Kambadakone","year":"2018","unstructured":"Kambadakone AR, Fung A, Gupta RT et al (2018) LI-RADS technical requirements for CT, MRI, and contrast-enhanced ultrasound. Abdom Radiol 43(1):56\u201374","journal-title":"Abdom Radiol"},{"issue":"12","key":"2259_CR19","doi-asserted-by":"publisher","first-page":"8520","DOI":"10.21037\/qims-24-941","volume":"14","author":"X He","year":"2024","unstructured":"He X, Li Y, Han D et al (2024) Gadoxetic acid disodium (Gd-EOB-DTPA) contrast-enhanced abbreviated MRI for hepatocellular carcinoma surveillance in at-risk patients: a multicenter study in China. Quant Imaging Med Surg 14(12):8520\u20138537","journal-title":"Quant Imaging Med Surg"},{"issue":"3","key":"2259_CR20","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2214\/AJR.14.12986","volume":"204","author":"RM Marks","year":"2015","unstructured":"Marks RM, Ryan A, Heba ER et al (2015) Diagnostic per-patient accuracy of an abbreviated hepatobiliary phase gadoxetic acid-enhanced MRI for hepatocellular carcinoma surveillance. AJR Am J Roentgenol 204(3):527\u2013535","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"2259_CR21","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/bimj.201600093","volume":"59","author":"S Vanbelle","year":"2017","unstructured":"Vanbelle S (2017) Comparing dependent kappa coefficients obtained on multilevel data. Biom J 59(5):1016\u20131034","journal-title":"Biom J"},{"issue":"2","key":"2259_CR22","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/1094428104263672","volume":"7","author":"GA Ballinger","year":"2004","unstructured":"Ballinger GA (2004) Using generalized estimating equations for longitudinal data analysis. Organ Res Methods 7(2):127\u2013150","journal-title":"Organ Res Methods"},{"issue":"11","key":"2259_CR23","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/j.acra.2014.07.004","volume":"21","author":"NA Obuchowski","year":"2014","unstructured":"Obuchowski NA, Subhas N, Schoenhagen P (2014) Testing for interchangeability of imaging tests. Acad Radiol 21(11):1483\u20131489","journal-title":"Acad Radiol"},{"issue":"2","key":"2259_CR24","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/jmri.26835","volume":"51","author":"G Khatri","year":"2020","unstructured":"Khatri G, Pedrosa I, Ananthakrishnan L et al (2020) Abbreviated-protocol screening MRI vs. complete-protocol diagnostic MRI for detection of hepatocellular carcinoma in patients with cirrhosis: an equivalence study using LI-RADS v2018. J Magn Reson Imaging 51(2):415\u2013425","journal-title":"J Magn Reson Imaging"},{"issue":"4","key":"2259_CR25","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1111\/1365-2656.12382","volume":"84","author":"MT Puth","year":"2015","unstructured":"Puth MT, Neuh\u00e4user M, Ruxton GD (2015) On the variety of methods for calculating confidence intervals by bootstrapping. J Anim Ecol 84(4):892\u2013897","journal-title":"J Anim Ecol"},{"key":"2259_CR26","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cgh.2021.02.036","volume":"20","author":"MV Chan","year":"2022","unstructured":"Chan MV, Huo YR, Trieu N et al (2022) Noncontrast MRI for hepatocellular carcinoma detection: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 20:44\u201356","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"2259_CR27","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1016\/j.acra.2024.01.028","volume":"31","author":"ST Maung","year":"2024","unstructured":"Maung ST, Deepan N, Decharatanachart P, Chaiteerakij R (2024) Abbreviated MRI for hepatocellular carcinoma surveillance\u2013a systematic review and meta-analysis. Acad Radiol 31(8):3142\u20133156","journal-title":"Acad Radiol"},{"issue":"5","key":"2259_CR28","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1002\/jmri.28665","volume":"58","author":"SK Jeon","year":"2023","unstructured":"Jeon SK, Lee DH, Hur BY et al (2023) Abbreviated MRI for secondary surveillance of recurrent hepatocellular carcinoma after presumed curative treatment. J Magn Reson Imaging 58(5):1375\u20131383","journal-title":"J Magn Reson Imaging"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-026-02259-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11547-026-02259-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-026-02259-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:31:15Z","timestamp":1791826275000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11547-026-02259-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":28,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["2259"],"URL":"https:\/\/doi.org\/10.1007\/s11547-026-02259-0","relation":{},"ISSN":["1826-6983"],"issn-type":[{"value":"1826-6983","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with ethical standards, involving human participants.","order":2,"name":"Ethics","label":"Human or animals rights","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed written consent was obtained from all individual participants involved in the study. All participants were fully informed about the purpose of the study, the procedures involved and their rights, including the right to withdraw at any time without consequence.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}